1.
Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials
by Senderowicz, A M
Investigational new drugs, 1999, Vol.17 (3), p.313
2.
Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthrene-induced tumorigenesis
by Elangovan, V
Cancer letters, 1994, Vol.87 (1), p.107-113
3.
Botanical influences on cardiovascular disease
by Miller, A L
Alternative medicine review, 1998-12, Vol.3 (6), p.422-431
4.
Mediterranean Diet and Coronary Heart Disease: Are Antioxidants Critical?
by TRICHOPOULOU, A
Nutrition reviews, 1999-08, Vol.57 (8), p.253-255
5.
Role of Medicinal Plants, Herbs, and Spices in Protecting Human Health
by Balentine, Douglas A.
Nutrition reviews, 1999-09, Vol.57 (9), p.41-45
6.
Effect of (−)-epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines
by Taniguchi, Shun'ichiro
Cancer letters, 1992, Vol.65 (1), p.51-54
7.
Influence of vehicle, distant topical delivery, and biotransformation on the chemopreventive activity of apigenin, a plant flavonoid, in mouse skin
by LI, B
Pharmaceutical research, 1996, Vol.13 (10), p.1530-1534
8.
Effects of Morin on an Experimental Model of Acute Colitis in Rats
by Ocete, M. Angeles
Pharmacology, 1998-11, Vol.57 (5), p.261-270
9.
The Protection of the Retina from Ischemic Injury by the Free Radical Scavenger EGb 761 and Zinc in the Cat Retina
by Kim, Si-Yeol
Ophthalmologica (Basel), 1998-08, Vol.212 (4), p.268-274
10.
Anti-inflammatory activity of myricetin-3-O-beta-D-glucuronide and related compounds
by Hiermann, A
Inflammation research, 1998-11, Vol.47 (11), p.421-427
11.
Anti-inflammatory activity and inhibition of arachidonic acid metabolism by flavonoids
by Ferrándiz, M. L.
Agents and Actions, 1991-03, Vol.32 (3-4), p.283-288
12.
Chemoprevention of cancer for the next millennium — quo vadis?
by Zänker, Kurt S
Cancer letters, 1999, Vol.143, p.S7-S11
13.
Dietary bioflavonoids, chalcones, and related alkenones in prevention and treatment of cancer
by Varma, Rajender S
Nutrition (Burbank, Los Angeles County, Calif.), 1996, Vol.12 (9), p.643-645
14.
Flavonoid-mediated tumor growth suppression demonstrated by in vivo study
by KAMEI, H
Cancer biotherapy & radiopharmaceuticals, 1996, Vol.11 (3), p.193-196
15.
Nutriceuticals for cardiovascular health
by Cooke, John P
The American journal of cardiology, 1998, Vol.82 (10), p.S43-S46
16.
Flavone 8-acetic acid: our current understanding of its mechanism of action in solid tumours
by CUMMINGS, J
Cancer chemotherapy and pharmacology, 1989, Vol.24 (5), p.269-272
17.
Flavone acetic acid increases the cytotoxicity of mitomycin C when combined with hyperthermia
by TAKEUCHI, H
Cancer chemotherapy and pharmacology, 1996, Vol.38 (1), p.1-8
18.
Activity of flavone acetic acid (NSC-347512) against solid tumors of mice
by Corbett, T H
Investigational new drugs, 1986, Vol.4 (3), p.207
19.
Phase I and pharmacology study of flavone acetic acid administered two or three times weekly without alkalinization
by DE FORNI, M
Cancer chemotherapy and pharmacology, 1995, Vol.35 (3), p.219-224
20.
Nitric oxide : its production in host-cell-infiltrated EMT6 spheroids and its role in tumour cell killing by flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid
by THOMSEN, L. L
Cancer chemotherapy and pharmacology, 1992, Vol.31 (2), p.151-155
Filter electronic articles 67 Hits
Remove Filters
